Table 2

Unadjusted and adjusted ORs* for clinical improvement in 100 patients with COVID-19: 96 improved vs 4 did not improve

Risk factor (sample size)UnadjustedAdjusted†
OR95% CIP valueOR95% CIP value
Bromhexine (n=48) vs standard treatment (n=52)0.920.15 to 5.660.934.150.13 to 138.250.43
Obese‡ (n=47) vs not obese (n=53)0.880.14 to 5.430.892.110.08 to 56.390.66
Renal disease (n=5) vs no renal disease (n=95)0.040.004 to 0.330.0030.040.004 to 0.420.007
Smoker (n=13) vs non-smoker (n=87)1.460.07 to 31.670.810.990.05 to 18.140.99
  • *ORs were calculated from logistic regression models that used Firth’s penalized maximum likelihood estimation.

  • †Each OR is adjusted for the remaining variables that are found in the table.

  • ‡Defined as a Body Mass Index of ≥30 kg/m2.